B+
Bull case
20%
Probability
Target price
$170.10
+95.6% vs current
ABT
Abbott LaboratoriesDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$141.25
+62.4% vs current
B-
Bear case
20%
Probability
Target price
$108.00
+24.2% vs current
AI sentiment snapshot
Latest data as of 2026-01-24
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Near-term tone turned negative after Jan 22 results due to a revenue miss and softer 2026 guidance, but analyst targets and dividend yield arguments keep longer-term sentiment constructive; filings show active insider/institutional moves that have increased debate and volatility.
RankAlpha Sentiment AI - 2026-01-24
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-24eventRegulatory / approval milestones (window)High impact
Discrete regulatory or labeling decisions for devices remain material event risks/rewards; no single public date found, so date set to conservative near-term window end.
2026-04-24catalystNext quarterly results (estimated)High impact
Next quarterly report is the nearest price catalyst; date conservatively estimated as an upcoming earnings window and likely to move shares on beats/misses.
2027-01-24catalystDiagnostics and devices recoveryHigh impact
Sustained recovery in diagnostics demand and device sales could drive multi-quarter upside, consistent with analyst upside scenarios.
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-24 • Updated nightlySource: Internal modelMethodology